forecast

Survival gap attributed to insufficient field intensity

The reason five-year survival is not near 80 percent is that the field dose is still too low, and preclinical animal models suggest the tumors could be killed with higher dose, so engineering higher intensity is the company's path forward.

forecastpending

Speaker

Bill

Evidence Quote

“we can kill all these tumors. We just need to get the dose higher”

Source

Novocure: Using Physics to Fight Cancer— Business Breakdowns
Created: 11/19/2026, 2:27:17 AM

Your notes

Loading notes...